In conclusion, above findings suggest that lomerizine 2HCl markedly suppresses the growth of tumor in vivo by suppressing the PI3K/AKT/mTOR signaling pathway, which is consistent with the results observed in vitro. The gene discussed is AKT1; the disease is neoplasm.